188 related articles for article (PubMed ID: 25488473)
21. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
22. Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy.
Ikeda K; Yamamoto D; Usui K; Takeuchi H; Oka N; Katoh N; Yazaki M; Kametani F; Nishino I; Hisahara S
Intern Med; 2023 Aug; 62(15):2261-2266. PubMed ID: 36543209
[TBL] [Abstract][Full Text] [Related]
23. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
24. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis.
Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C
Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071
[TBL] [Abstract][Full Text] [Related]
25. A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.
Shimizu Y; Takeuchi M; Matsumura M; Tokuda T; Iwata M
Amyloid; 2006 Mar; 13(1):37-41. PubMed ID: 16690499
[TBL] [Abstract][Full Text] [Related]
26. Novel transthyretin gene mutation in familial amyloid neuropathy in India: Case.
Rohatgi S; Nirhale S; Manohar P; Rao P; Naphade P; Khan FMA; Dave D; Sravya Kotaru VV; Gupta S; Gitay A; Dubey P
Ann Afr Med; 2022; 21(3):296-298. PubMed ID: 36204920
[TBL] [Abstract][Full Text] [Related]
27. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
28. Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report.
Terrier B; Colombat M; Beugnet C; Quéant A; London J; Daudin JB; Le Jeunne C; Mouthon L; Monnet D; Cauquil C; Lacroix C; Adams D; Brézin A; Valleix S
J Med Case Rep; 2017 Aug; 11(1):222. PubMed ID: 28802308
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
Devarapalli S; Zhou DJ; Dyck PJB; Piccione EA
J Clin Neuromuscul Dis; 2019 Jun; 20(4):207-209. PubMed ID: 31135624
[TBL] [Abstract][Full Text] [Related]
30. Neuropathology of central nervous system involvement in TTR amyloidosis.
Taipa R; Sousa L; Pinto M; Reis I; Rodrigues A; Oliveira P; Melo-Pires M; Coelho T
Acta Neuropathol; 2023 Jan; 145(1):113-126. PubMed ID: 36198883
[TBL] [Abstract][Full Text] [Related]
31. Unusual presentation of rare
Gupta R; Lin M; Bokhari S
Future Cardiol; 2022 Jun; 18(6):471-476. PubMed ID: 35549533
[TBL] [Abstract][Full Text] [Related]
32. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
[TBL] [Abstract][Full Text] [Related]
33. A novel ATTR L32V mutation causes familial amyloid polyneuropathy in a Bolivian family.
Martínez-Ulloa PL; Vallejo M; Corral I; García-Barragán N; Alcazar A; Martínez-Alonso E; Martínez-Poles J; Pian H; Jiménez-Escrig A
J Peripher Nerv Syst; 2017 Sep; 22(3):208-212. PubMed ID: 28646538
[TBL] [Abstract][Full Text] [Related]
34. Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease.
Fenoglio R; Baldovino S; Barreca A; Bottasso E; Sciascia S; Sbaiz L; Papotti M; Roccatello D
Nephron; 2022; 146(5):481-488. PubMed ID: 35307708
[TBL] [Abstract][Full Text] [Related]
35. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
36. Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation.
Riboldi G; Del Bo R; Ranieri M; Magri F; Sciacco M; Moggio M; Bresolin N; Corti S; Comi GP
Case Rep Neurol; 2011 Feb; 3(1):62-8. PubMed ID: 21490715
[TBL] [Abstract][Full Text] [Related]
37. Hereditary Transthyretin Amyloidosis in Eight Chinese Families.
Meng LC; Lyu H; Zhang W; Liu J; Wang ZX; Yuan Y
Chin Med J (Engl); 2015 Nov; 128(21):2902-5. PubMed ID: 26521788
[TBL] [Abstract][Full Text] [Related]
38. Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.
Pinheiro F; Varejão N; Esperante S; Santos J; Velázquez-Campoy A; Reverter D; Pallarès I; Ventura S
FEBS J; 2021 Jan; 288(1):310-324. PubMed ID: 32324953
[TBL] [Abstract][Full Text] [Related]
39. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.
Thimm A; Oubari S; Hoffmann J; Carpinteiro A; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Röcken C; Diebold I; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
BMC Neurol; 2022 Dec; 22(1):469. PubMed ID: 36494773
[TBL] [Abstract][Full Text] [Related]
40. Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy.
Dardiotis E; Kyriakides T
Curr Neuropharmacol; 2023; 21(3):471-481. PubMed ID: 36366846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
